Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies
Abstract The global prevalence of obesity is rapidly in creasing, significantly increasing the incidence of heart failure with preserved ejection fraction (HFpEF). Obesity, one of the most common clinical phenotypes of HFpEF, facilitates the onset and progression of HFpEF via multiple pathophysiolog...
Saved in:
| Main Authors: | Wenwen Zheng, Qianxian Qi, Jie Li, Chaojie He, Hongyan Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-025-01917-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications
by: Xiangling Duan, et al.
Published: (2025-04-01) -
Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
by: Satyam Sarma, et al.
Published: (2020-11-01) -
Tirzepatide - role in obesity, health and physical wellness. Information overview
by: Anna Hanslik, et al.
Published: (2025-02-01) -
Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice
by: Fang Lv, et al.
Published: (2024-12-01) -
Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
by: Alexander Fuerlinger, et al.
Published: (2025-01-01)